INTECH Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.89M	Buy	33,497 +29,684	+778%	+$1.73M	0.02%	727
2025 Q4	$227K	Sell	3,813 -11,329	-75%	-$617K	﹤0.01%	1916
2025 Q3	$820K	Sell	15,142 -672	-4%	-$38.4K	0.01%	1294
2025 Q2	$869K	Sell	15,814 -16,318	-51%	-$961K	0.01%	1277
2025 Q1	$2.27M	Sell	32,132 -129,603	-80%	-$8.72M	0.02%	686
2024 Q4	$10.6M	Buy	161,735 +107,879	+200%	+$7.23M	0.1%	160
2024 Q3	$3.79M	Sell	53,856 -4,167	-7%	-$348K	0.04%	321
2024 Q2	$4.78M	Buy	58,023 +21,669	+60%	+$1.8M	0.06%	263
2024 Q1	$3.18M	Buy	36,354 +11,186	+44%	+$1M	0.04%	294
2023 Q4	$2.43M	Sell	25,168 -3,949	-14%	-$349K	0.04%	313
2023 Q3	$2.58M	Buy	29,117 +1,237	+4%	+$110K	0.04%	318
2023 Q2	$2.42M	Buy	27,880 +3,537	+15%	+$333K	0.02%	353
2023 Q1	$2.37M	Buy	24,343 +10,539	+76%	+$1.09M	0.02%	438
2022 Q4	$1.43M	Buy	13,804 +706	+5%	+$66.3K	0.01%	475
2022 Q3	$1.11M	Sell	13,098 -11,131	-46%	-$991K	0.01%	495
2022 Q2	$2.01M	Buy	+24,229	New	+$1.93M	0.01%	451